New Paradigms and Emerging Frontiers: The Immunotherapy Revolution in Multiple Myeloma

This symposium was recorded live from the 58th ASH Annual Meeting & Exposition on December 4, 2015. Watch and learn what the experts are saying about newly approved immunotherapeutic agents for multiple myeloma and those that are on the horizon.

Reviewed on January 17, 2017 for clinical relevance.

Last modified: February 8, 2017